Intellia Therapeutics, Inc. NTLA

NASDAQ Price as of Nov 17, 2026 · Fiscal year ended Dec 31, 2025 · Latest quarter Sep 30, 2026

$9.78
$7.90
$18.48
Market cap
$1.37B
P/E (GAAP, TTM)
—
P/E (operating)
—
Dividend yield
0.0%
Revenue growth YoY
-48.0%
EPS growth YoY
1.1%
ROIC
-67.5%
Piotroski F-score
3

Three ways to read the P/E

P/E (GAAP, TTM)
—

Net income of the last 4 quarters. Includes investment gains and one-time items.

P/E (GAAP, annual)
—

Net income of the latest fiscal year. Includes investment gains and one-time items.

P/E (operating)
—

After-tax operating income only: the core business.

P/E (excl. gains)
—

Net income after removing identified investment and asset-sale gains.

How it has changed

Values as they were known at each quarter-end. Green = moved in the better direction, red = worse.

Metric 2026Q3 2026Q2Change QoQ 2025Q3Change YoY
Revenue growth YoY (qtr) -46.2% -9.5%-36.7 pts 104.8%-151.0 pts
EPS growth YoY (qtr) 18.4% 26.4%-8.0 pts 35.5%-17.2 pts
Revenue growth (TTM) 12.6% 45.0%-32.5 pts 15.0%-2.4 pts
EPS growth (TTM) 28.8% 32.7%-3.9 pts 14.6%+14.2 pts
P/E (GAAP, TTM) — —— ——
P/E (operating) — —— ——
P/E (excl. gains) — —— ——
P/B 1.95 2.73-0.79 ——
ROIC -67.5% -67.5%0.0 pts -61.8%-5.7 pts
Net margin -609.9% -609.9%0.0 pts -896.8%+286.9 pts
Dividend yield 0.0% 0.0%0.0 pts ——
EPS (TTM) -3.34 -3.52+5.1% -4.69+28.8%
Price $12.05 $16.93-28.8% ——

History by quarter-end

Reported quarters

Quarter endedRevenueQoQYoY EPSQoQYoYNet margin
Sep 30, 2026 $7.16M -6.5% -48.0% -0.91 -13.8% 1.1% -1,779.8%
Jun 30, 2026 $7.66M -49.1% -46.2% -0.80 1.2% 18.4% -1,392.3%
Mar 31, 2026 $15.05M -34.6% -9.5% -0.81 0.0% 26.4% -639.5%
Dec 31, 2025 * $23.02M 67.0% 78.8% -0.81 12.0% 36.2% -416.2%
Sep 30, 2025 $13.78M -3.3% 51.3% -0.92 6.1% 31.3% -735.2%
Jun 30, 2025 $14.25M -14.3% 104.8% -0.98 10.9% 35.5% -710.8%
Mar 31, 2025 $16.63M 29.2% -42.5% -1.10 13.4% 1.8% -687.6%
Dec 31, 2024 * $12.87M 41.3% 771.6% -1.27 5.2% 13.6% -1,001.2%
Sep 30, 2024 $9.11M 31.0% -24.0% -1.34 11.8% 2.9% -1,489.5%
Jun 30, 2024 $6.96M -76.0% -48.8% -1.52 -35.7% -8.6% -2,112.6%
Mar 31, 2024 $28.94M 1,609.4% 129.5% -1.12 23.8% 4.3% -371.3%
Dec 31, 2023 * -$1.92M -116.0% -114.1% -1.47 -6.5% -6.5% 6,894.2%

* Q4 is not filed separately. It is calculated as the fiscal year minus the first three quarters.

All figures

Price & size
Fiscal year end Dec 31, 2025 End date of the latest annual (10-K) report used.
Price date Nov 17, 2026 Date of the latest closing price used.
Price $9.78 Latest closing price.
Market cap $1.37B Price × shares outstanding.
Enterprise value $1.22B Market cap + debt − cash: the price of the whole business.
Shares 140.36M Shares outstanding used for market cap.
Valuation
P/E (GAAP, annual) — Price ÷ diluted earnings per share of the latest fiscal year. Uses NET income, so it includes investment gains and one-time items. Blank when earnings are negative.
P/E (GAAP, TTM) — Price ÷ the sum of the last four quarters of diluted EPS. Like P/E but more current. Includes investment gains and one-time items.
P/E (operating) — Market cap ÷ after-tax OPERATING income (latest fiscal year). Core business only: leaves out interest, investment gains and one-time items.
P/E (operating, TTM) — Market cap ÷ after-tax operating income of the last four quarters.
P/E (excl. gains) — Market cap ÷ net income after removing identified investment and asset-sale gains (after tax). Equals the GAAP P/E when no gains were identified.
PEG — P/E ÷ 3-year EPS growth rate (in %). Below 1 can mean growth is cheap.
PEG (TTM) — TTM P/E ÷ TTM EPS growth rate (in %).
Earnings yield -30.1% Net income ÷ market cap. The inverse of the P/E.
Earnings yield (TTM) -34.0% TTM EPS ÷ price.
P/B 2.04 Market cap ÷ shareholders' equity. Blank when equity is negative.
P/S 20.29 Market cap ÷ revenue of the latest fiscal year.
P/S (TTM) 25.96 Market cap ÷ revenue of the last four quarters.
P/FCF — Market cap ÷ free cash flow (operating cash flow − capital spending). Blank when FCF is negative.
EV/EBITDA — Enterprise value ÷ EBITDA. Useful for comparing companies with different debt levels.
EV/EBIT — Enterprise value ÷ operating income.
EV/Sales 17.99 Enterprise value ÷ revenue.
Book value / share 4.78 Shareholders' equity ÷ shares.
FCF yield -28.8% Free cash flow ÷ market cap.
Operating vs. one-time earnings
Operating EPS -2.48 After-tax operating income per share (latest fiscal year).
Investment gains -$899.00K Gains (+) or losses (−) on investments inside net income, when the company reported them with the standard tags. Blank = none identified.
Asset-sale gains -$527.00K One-time gains or losses from selling property, assets or businesses. Blank = none identified.
Non-operating income — Pre-tax income minus operating income: interest, investment results and one-time items combined.
Gains as % of net income -0.3% Identified investment and asset-sale gains (after tax) as a share of net income. A high value means reported earnings are flattered by non-core gains.
Latest quarter & trailing 12 months
Latest quarter Sep 30, 2026 End date of the most recent reported quarter.
Revenue (qtr) $7.16M Revenue of the latest reported quarter.
Net income (qtr) -$127.49M Net income of the latest reported quarter.
EPS (qtr) -0.91 Diluted EPS of the latest reported quarter.
Revenue growth YoY (qtr) -48.0% Latest quarter revenue vs the same quarter a year earlier.
Revenue growth QoQ (qtr) -6.5% Latest quarter revenue vs the previous quarter.
EPS growth YoY (qtr) 1.1% Latest quarter EPS vs the same quarter a year earlier.
EPS growth QoQ (qtr) -13.8% Latest quarter EPS vs the previous quarter.
Net income growth YoY (qtr) -25.8% Latest quarter net income vs the same quarter a year earlier.
Net income growth QoQ (qtr) -19.6% Latest quarter net income vs the previous quarter.
Gross margin (qtr) — Gross profit ÷ revenue in the latest quarter.
Operating margin (qtr) -1,707.7% Operating income ÷ revenue in the latest quarter.
Net margin (qtr) -1,779.8% Net income ÷ revenue in the latest quarter.
Revenue (TTM) $52.89M Revenue of the last four quarters.
Net income (TTM) -$426.14M Net income of the last four quarters.
EPS (TTM) -3.33 Sum of the last four quarters of diluted EPS.
Revenue growth (TTM) -8.1% Last four quarters of revenue vs the four quarters before.
EPS growth (TTM) 22.0% Last four quarters of EPS vs the four quarters before.
Net income growth (TTM) 4.4% Last four quarters of net income vs the four quarters before.
Dividends & shareholder returns
Dividend yield 0.0% Dividends paid per share over the last 12 months ÷ price.
Dividend / share (TTM) — Dividends per share paid over the last 12 months.
Payout ratio — Dividends per share ÷ EPS. Above 100% means the dividend exceeds earnings.
FCF payout ratio — Dividends ÷ free cash flow.
Dividend growth (1y) — Dividends per share vs the same 12-month window a year earlier.
Dividend CAGR (3y) — Annualised dividend growth over 3 years.
Dividend CAGR (5y) — Annualised dividend growth over 5 years.
Payments (12m) — Number of dividend payments in the last 12 months.
Last ex-dividend date — Most recent ex-dividend date.
Buyback yield 0.0% Share repurchases ÷ market cap.
Shareholder yield 0.0% Dividend yield + buyback yield.
Profitability
Gross margin — Gross profit ÷ revenue (latest fiscal year).
EBITDA margin -637.2% EBITDA ÷ revenue.
Operating margin -651.7% Operating income ÷ revenue.
Net margin -609.9% Net income ÷ revenue.
FCF margin -585.0% Free cash flow ÷ revenue.
ROE -61.5% Return on equity: net income ÷ shareholders' equity. Blank when equity is negative.
ROA -49.0% Return on assets: net income ÷ total assets.
ROIC -67.5% Return on invested capital: after-tax operating income ÷ (equity + debt − cash).
Growth (annual)
Revenue growth (annual) 16.9% Latest fiscal year revenue vs the year before.
Net income growth (annual) 20.5% Latest fiscal year net income vs the year before.
EPS growth (annual) 27.4% Latest fiscal year diluted EPS vs the year before.
Revenue CAGR (3y) 9.1% Annualised revenue growth over 3 fiscal years.
EPS CAGR (3y) — Annualised EPS growth over 3 fiscal years.
Financial health
Current ratio 5.08 Current assets ÷ current liabilities. Above 1 means short-term bills are covered.
Quick ratio 5.08 (Current assets − inventory) ÷ current liabilities.
Cash ratio 1.50 Cash ÷ current liabilities.
Debt / equity 0.00 Total debt ÷ shareholders' equity. Blank when equity is negative.
Debt / assets 0.00 Total debt ÷ total assets.
Debt / EBITDA — Total debt ÷ EBITDA: roughly how many years of earnings it takes to repay debt.
Net debt / EBITDA — (Debt − cash) ÷ EBITDA. Negative means more cash than debt.
Interest coverage — Operating income ÷ interest expense.
Earnings quality
FCF conversion — Free cash flow ÷ net income. Above 100% means profits turn into real cash.
Accruals ratio -2.1% (Net income − operating cash flow) ÷ assets. High values can signal low-quality earnings.
Stock comp % revenue 118.5% Share-based compensation ÷ revenue.
R&D % revenue 574.6% Research & development spending ÷ revenue.
SG&A % revenue — Selling, general & administrative expense ÷ revenue.
Tax rate used 21.0% Effective tax rate used for after-tax figures (capped 0–35%; 21% when unknown).
Efficiency
Asset turnover 0.08 Revenue ÷ total assets.
Days sales outstanding 51 Average days to collect payment from customers.
Days inventory — Average days inventory is held.
Days payables — Average days to pay suppliers.
Trading & momentum
52-week high $18.48 Highest price in the last 52 weeks.
52-week low $7.90 Lowest price in the last 52 weeks.
From 52-week high -47.1% How far below the 52-week high the price is (0% = at the high).
Above 52-week low 23.8% How far above the 52-week low the price is.
Avg volume (30d) 3.29M Average shares traded per day over the last 30 days.
Avg $ volume (30d) $37.05M Average dollars traded per day over the last 30 days: a liquidity measure.
Scores
Piotroski F-score 3 Nine yes/no tests of profitability, leverage and efficiency. 8–9 is strong, 0–2 is weak. Missing data counts as a fail.
Altman Z-score -0.53 Bankruptcy-risk score. Above 2.99 is safe, below 1.81 is distress. Not meaningful for banks and insurers.
Reported figures (latest fiscal year)
Revenue $67.67M Revenue of the latest fiscal year.
Net income -$412.69M Net income of the latest fiscal year.
Diluted EPS -3.81 Diluted earnings per share of the latest fiscal year.
EBITDA -$431.22M Operating income + depreciation & amortization.
Free cash flow -$395.87M Operating cash flow − capital spending.
Total debt $0 Long-term plus current debt.
Cash $155.46M Cash and equivalents.
Equity $671.39M Shareholders' equity.
Total assets $842.13M Total assets.